However, the present study demonstrates that individual targeting of either FOXM1 or RHNO1, using shRNA or CRISPR-Cas9, significantly reduces HGSC cell clonogenic growth, suggesting that each protein contributes to cancer phenotypes. This evidence concerns the gene RHNO1 and cancer.